Arbutus Biopharma Corporation Common Stock

ABUS CA03879J1003

💰
Capitalization
Small-cap

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.

🔗
Website
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
9
🙍
Insiders
6
Person Price Shares Total Published Completed
Hastings David C
CFO 		3.28
USD 		22,183
Sold 		72,827
USD 		04/02/2025 04/02/2025
Sims Karen
CMO 		3.28
USD 		19,348
Sold 		63,519
USD 		04/02/2025 04/02/2025
Mcelhaugh Michael J.
CEO 		3.28
USD 		23,790
Sold 		78,103
USD 		04/02/2025 04/02/2025
Naftzger J. Christopher
CCO 		3.28
USD 		11,333
Sold 		37,206
USD 		04/02/2025 04/02/2025
Manchester Keith S
 3.69
USD 		8,846
Sold 		32,637
USD 		14/08/2024 14/08/2024
Sofia Michael J.
CSO 		2.31
USD 		9,982
Sold 		23,083
USD 		01/02/2024 02/02/2024
Sims Karen
CMO 		2.31
USD 		4,358
Sold 		10,078
USD 		01/02/2024 02/02/2024
Mcelhaugh Michael J.
CEO 		2.31
USD 		10,164
Sold 		23,504
USD 		01/02/2024 02/02/2024
Hastings David C
CFO 		2.31
USD 		9,593
Sold 		22,184
USD 		01/02/2024 02/02/2024
Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Arbutus Biopharma Corporation Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last 52W Low 52W High All-Time Low All-Time High β
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Mcelhaugh Michael J. 2 101,606.82 50,803.41 02/02/2024 04/02/2025
Hastings David C 2 95,010.60 47,505.30 02/02/2024 04/02/2025
Sims Karen 2 73,597.36 36,798.68 02/02/2024 04/02/2025
Naftzger J. Christopher 1 37,206.24 37,206.24 04/02/2025 04/02/2025
Manchester Keith S 1 32,637.32 32,637.32 14/08/2024 14/08/2024
Sofia Michael J. 1 23,083.38 23,083.38 02/02/2024 02/02/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.